Recent Quotes (30 days)

You have no recent quotes
chg | %

Solarvest Bioenergy Inc  

(Public, CVE:SVS)   Watch this stock  
Find more results for SVS
0.270
0.000 (0.00%)
Dec 9 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.16 - 0.35
Open     -
Vol / Avg. 100.00/1,256.00
Mkt cap 6.35M
P/E     -
Div/yield     -
EPS -0.08
Shares 21.78M
Beta 0.86
Inst. own     -

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -189.99% -122.62%
Return on average equity - -592.64%
CDP Score - -

Address

439 Helmcken St
VANCOUVER, BC V6B 2E6
Canada
+1-604-6843323 (Phone)
+1-604-6843350 (Fax)

Website links

Description

Solarvest BioEnergy Inc. is an algae technology company, which is engaged in the development of specially selected algal-based production systems to produce natural-based green commercial products, such as nutritional products, oils and biologic therapies, among others. The Company is focused on developing algae strains that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA), which are a form of Omega 3 fatty acids used by the food enhancement and Nutraceutical markets. It is also focuses on developing algae strains that can be used to produce proteins with the first such target being a therapeutic that has use in human and animal orthopedic surgery and genetically modified algae strain that can be used to produce hydrogen. It is also focused on custom producing organic chemical-free Omega 3s and other nutritional oils. Its subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc. The Company has not generated any revenue.

Officers and directors

Kenneth A. Cawkell Chairman of the Board, Secretary
Age: 65
Gerri J. Greenham President, Chief Executive Officer, Director
Joseph Heng Chief Financial Officer
William M. Cheliak Independent Director
Mark S. Ledwell Independent Director
Michael L. O'Brien Independent Director